Regarding the genetic architecture of DS, a de novo mutation in the gene SCN1A which encodes for an α (pore-forming) subunit of the brain voltage gated sodium channel type-1 (NaV1.1), occurs in a large majority of patients [7]. This evidence concerns the gene SCN1A and Dravet syndrome.